Researchers reviewed the prescribing of first?line checkpoint inhibitors (CPIs) for the treatment of patients with metastatic melanoma in England since their introduction in 2014 to better understand the clinical practice and used national databases to link outcomes such as survival and treatment toxicity of treated patients.
Scientific Publications
Predictors of long-term anxiety and depression in uveal melanoma survivors: A cross-lagged five-year analysis
Data were obtained from sample of 453 uveal melanoma survivors who completed observations 6?, 12?, 24?, 36?, 48? and 60?months postdiagnosis and missed no two consecutive observations.
Disparities in the occurrence of late effects following treatment among adolescent and young adult melanoma survivors
Melanoma is the third most common cancer in the adolescent and young adult (AYA) population, however no studies have addressed the occurrence of adverse health conditions following melanoma treatment in these survivors.
Fatal pediatric melanomas diverse in presentation
Malignant melanomas in children and adolescents are thankfully rare, but they can be challenging to diagnose, and fatal disease can manifest itself in any of several different ways, results of a retrospective multicenter study showed.